Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Cash flows provided by (used in) operating activities:
Net earnings	$ 299.3	$ 108.7
Adjustments to reconcile net earnings to cash provided by operating activities:
Depreciation and amortization	267.6	246.9
Share-based compensation	14.0	12.7
Inventory step-up	14.6	153.7
Changes in operating assets and liabilities, net of effect of acquisitions:
Income taxes	(86.9)	(33.7)
Receivables	26.8	(83.4)
Inventories	(11.5)	38.3
Accounts payable and accrued expenses	(137.0)	(116.3)
Other assets and liabilities	(111.5)	(54.1)
Net cash provided by operating activities	275.4	272.8
Cash flows provided by (used in) investing activities:
Additions to instruments	(86.4)	(85.1)
Additions to other property, plant and equipment	(43.1)	(27.6)
Purchases of investments		(0.3)
Sales of investments		223.5
Other investing activities	(3.6)	(14.7)
Net cash used in investing activities	(133.1)	95.8
Cash flows provided by (used in) financing activities:
Proceeds from multicurrency revolving facility	400.0
Payments on term loan	(150.0)	(400.0)
Net (payments) proceeds on other debt	(0.7)	0.3
Dividends paid to stockholders	(48.1)	(44.6)
Proceeds from employee stock compensation plans	66.1	31.3
Business combination contingent consideration payments	(6.0)
Restricted stock withholdings	(5.2)	(4.4)
Repurchase of common stock		(415.5)
Net cash (used in) provided by financing activities	256.1	(832.9)
Effect of exchange rates on cash and cash equivalents	7.0	1.8
(Decrease) increase in cash and cash equivalents	405.4	(462.5)
Cash and cash equivalents, beginning of year	634.1	1,459.3
Cash and cash equivalents, end of period	$ 1,039.5	$ 996.8